Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, Multiple System Atrophy
About this trial
This is an interventional diagnostic trial for Parkinson's Disease and Parkinsonism
Eligibility Criteria
Inclusion Criteria: Attending or referred to the Movement Disorder Clinic at the Mater Misericordiae University Hospital Current diagnosis of PD, PSP, MSA, CBS. Participant can give informed written consent. All participants must be capable of understanding and complying with the requirements of the protocol, including ability to attend for all visits. Participants have a minimum Montreal Cognitive Assessment score of ≥16 All participants must have visual acuity in at least one eye such that they can identify stimuli presented on a computer screen in front of them. Participants must be able to sit comfortably for a period of about 20 minutes Exclusion Criteria: Participant has large visual field defects that obscure visual targets within ±10 degrees of central vision. Participants has cognitive impairments that prohibit them from understanding the task description. History of stroke, traumatic brain injury or other condition which may interfere with eye movements. History of photosensitive epilepsy
Sites / Locations
- Dublin Neurological Institute at the Mater Misericordiae University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
Parkinson's disease
Progressive Supranuclear Palsy
Multiple System Atrophy
Corticobasal Syndrome
Eye tracking using Eyelink 1000 during free-viewing of videos
Eye tracking using Eyelink 1000 during free-viewing of videos
Eye tracking using Eyelink 1000 during free-viewing of videos
Eye tracking using Eyelink 1000 during free-viewing of videos